
John P. Heesakkers
Nijmegen, GE 6525GA, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 134 publications
Three-Year Efficacy and Safety of Revi Implantable Tibial Neuromodulation from the Pivotal OASIS Study.
Journal: The Journal of urology
Published: April 13, 2026
Correction to: Vibegron in overactive bladder: a comprehensive review of efficacy, safety and patient-reported outcomes.
Journal: World journal of urology
Published: November 03, 2025
Side effect management and procedural best practices with indwelling intravesical drug-releasing systems in the treatment of bladder cancer: recommendations from expert panels.
Journal: Current opinion in urology
Published: October 09, 2025
Impact of Revi® Implantable Tibial Neuromodulation on Quality of Life in Patients with Urgency Urinary Incontinence.
Journal: International urogynecology journal
Published: September 15, 2025
Carry-over effects in GAG therapy efficacy trial solution for bladder pain syndrome/interstitial cystitis (GETSBI study): an interim analysis.
Journal: BMJ open
Published: June 05, 2025
From Clinical Trials to Routine Practice: Are Urodynamics Still Useful?
Journal: European urology
Published: June 04, 2025
Recent Developments in the Diagnosis and Treatment of Urinary Incontinence.
Journal: European urology focus
Published: June 04, 2025
Genitourinary Toxicity, Function, and Quality of Life in Patients Undergoing Prostate Radiation Therapy-A Scoping Review.
Journal: Lower urinary tract symptoms
Published: May 31, 2025
Guidelines for clean intermittent catheterization in children.
Journal: World journal of pediatrics : WJP
Published: May 26, 2025
Vibegron in overactive bladder: a comprehensive review of efficacy, safety and patient-reported outcomes.
Journal: World journal of urology
Published: May 23, 2025
Editorial on the Abstracts from the 22nd Meeting of the Association of Academic European Urologists (AAEU).
Journal: European urology open science
Published: April 16, 2025
Sacral Neuromodulation in Multiple Sclerosis: The NEMISIS Study.
Journal: European urology focus
Published: January 31, 2025
Last Updated: 09/26/2026